{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T22:17:47Z","timestamp":1785449867791,"version":"3.56.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Dermatologic Clinics"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.det.2025.03.012","type":"journal-article","created":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T13:21:56Z","timestamp":1747228916000},"page":"453-460","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Genomics in Assessing Melanoma Prognosis"],"prefix":"10.1016","volume":"43","author":[{"given":"Angela","family":"Rosenberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danny","family":"Zakria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"DeBusk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milaan","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Burshtein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brooke","family":"Bartley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darrell","family":"Rigel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.det.2025.03.012_bib1","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3322\/caac.21763","article-title":"Cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.det.2025.03.012_bib2","unstructured":"American Cancer Society, Key statistics for melanoma skin cancer, 2023, American Cancer Society, Available at: https:\/\/www.cancer.org (Accessed 24 February 2025)."},{"issue":"6","key":"10.1016\/j.det.2025.03.012_bib3","doi-asserted-by":"crossref","first-page":"472","DOI":"10.3322\/caac.21409","article-title":"Melanoma staging: evidence-Based changes in the AJCC eighth edition cancer staging manual","volume":"67","author":"Gershenwald","year":"2017","journal-title":"CA Cancer J Clin"},{"issue":"36","key":"10.1016\/j.det.2025.03.012_bib4","doi-asserted-by":"crossref","first-page":"6199","DOI":"10.1200\/JCO.2009.23.4799","article-title":"Final version of 2009 AJCC melanoma staging and classification","volume":"27","author":"Balch","year":"2009","journal-title":"J Clin Oncol"},{"issue":"21","key":"10.1016\/j.det.2025.03.012_bib5","doi-asserted-by":"crossref","first-page":"3714","DOI":"10.3390\/cancers16213714","article-title":"The prognostic value of the 31-gene expression profile test in cutaneous melanoma: a systematic review and meta-analysis","volume":"16","author":"Durgham","year":"2024","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.det.2025.03.012_bib6","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.635488","article-title":"Cutaneous melanoma classification: the importance of high-throughput genomic technologies","volume":"11","author":"Scatena","year":"2021","journal-title":"Front Oncol"},{"issue":"3","key":"10.1016\/j.det.2025.03.012_bib7","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.hoc.2009.03.005","article-title":"Applications of genomics in melanoma oncogene discovery","volume":"23","author":"Berger","year":"2009","journal-title":"Hematol Oncol Clin North Am"},{"issue":"7","key":"10.1016\/j.det.2025.03.012_bib8","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1016\/j.cell.2024.02.041","article-title":"Cancer biomarkers: emerging trends and clinical implications for personalized treatment","volume":"187","author":"Passaro","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.det.2025.03.012_bib9","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2023.1290696","article-title":"An update on methods for detection of prognostic and predictive biomarkers in melanoma","volume":"11","author":"Adeuyan","year":"2023","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.det.2025.03.012_bib10","unstructured":"National Comprehensive Cancer Network, NCCN clinical practice guidelines in oncology: melanoma. Version 2.2023, Available at: https:\/\/www.nccn.org (Accessed 24 February 2025)."},{"issue":"5","key":"10.1016\/j.det.2025.03.012_bib11","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.jaad.2015.01.009","article-title":"Gene expression profiling for molecular staging of cutaneous melanoma in patients undergoing sentinel lymph node biopsy","volume":"72","author":"Gerami","year":"2015","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.det.2025.03.012_bib12","doi-asserted-by":"crossref","DOI":"10.2217\/mmt-2019-0016","article-title":"Prognostic gene expression profiling in melanoma: necessary steps to incorporate into clinical practice","volume":"6","author":"Grossman","year":"2019","journal-title":"Melanoma Manag"},{"issue":"12","key":"10.1016\/j.det.2025.03.012_bib13","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1097\/DSS.0000000000001588","article-title":"Estimation of prognosis in invasive cutaneous melanoma: an independent study of the accuracy of a gene expression profile test","volume":"44","author":"Greenhaw","year":"2018","journal-title":"Dermatol Surg"},{"issue":"4","key":"10.1016\/j.det.2025.03.012_bib14","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1007\/s13555-022-00709-x","article-title":"Expert consensus on the use of prognostic gene expression profiling tests for the management of cutaneous melanoma: Consensus from the skin cancer prevention working group","volume":"12","author":"Farberg","year":"2022","journal-title":"Dermatol Ther (Heidelb)"},{"key":"10.1016\/j.det.2025.03.012_bib15","article-title":"Integrating 31-Gene expression profiling with clinicopathologic features to optimize cutaneous melanoma sentinel lymph node metastasis prediction","volume":"5","author":"Whitman","year":"2021","journal-title":"JCO Precis Oncol"},{"key":"10.1016\/j.det.2025.03.012_bib16","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ejca.2019.10.027","article-title":"Clinical validation of a prognostic 11-gene expression profiling score in prospectively collected FFPE tissue of patients with AJCC v8 stage II cutaneous melanoma","volume":"125","author":"Amaral","year":"2020","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.det.2025.03.012_bib17","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ejca.2020.10.016","article-title":"Prognostic significance of an 11-gene RNA assay in archival tissue of cutaneous melanoma stage I-III patients","volume":"143","author":"Gambichler","year":"2021","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.det.2025.03.012_bib18","article-title":"Enhanced risk stratification for sentinel lymph node biopsy in head and neck melanoma using the merlin assay (CP-GEP)","author":"Pazhava","year":"2024","journal-title":"Ann Surg Oncol"},{"issue":"7","key":"10.1016\/j.det.2025.03.012_bib19","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1111\/ijd.15594","article-title":"Validation of CP-GEP (merlin assay) for predicting sentinel lymph node metastasis in primary cutaneous melanoma patients: a U.S. cohort study","volume":"60","author":"Yousaf","year":"2021","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.det.2025.03.012_bib20","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1200\/PO.19.00206","article-title":"Model combining tumor molecular and clinicopathologic risk factors predicts sentinel lymph node metastasis in primary cutaneous melanoma","volume":"4","author":"Bellomo","year":"2020","journal-title":"JCO Precis Oncol"},{"key":"10.1016\/j.det.2025.03.012_bib21","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1056\/NEJMoa1502583","article-title":"The genetic evolution of melanoma from precursor lesions","volume":"373","author":"Shain","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.det.2025.03.012_bib22","doi-asserted-by":"crossref","first-page":"4026","DOI":"10.3390\/cancers15164026","article-title":"BRAF mutations in melanoma: biological aspects, therapeutic implications, and circulating biomarkers","volume":"15","author":"Castellani","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.det.2025.03.012_bib23","first-page":"4621","article-title":"Contribution of MEK inhibition to BRAF\/MEK inhibitor combination treatment of BRAF-mutant melanoma: part 2 of the randomized, open-label, phase III COLUMBUS trial","volume":"41","author":"Ascierto","year":"2023","journal-title":"J Clin Orthod"},{"key":"10.1016\/j.det.2025.03.012_bib24","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.1016\/j.jid.2024.03.029","article-title":"The molecular evolution of melanoma distant metastases","volume":"144","author":"Bezrookove","year":"2024","journal-title":"J Investig Dermatol"},{"key":"10.1016\/j.det.2025.03.012_bib25","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1038\/s41598-024-52020-8","article-title":"Cooperative function of oncogenic MAPK signaling and the loss of pten for melanoma migration through the formation of lamellipodia","volume":"14","author":"Yasuta","year":"2024","journal-title":"Sci Rep"},{"key":"10.1016\/j.det.2025.03.012_bib26","article-title":"CDKN2A deletion in melanoma excludes T cell infiltration by repressing chemokine expression in a cell cycle-dependent manner","volume":"11","author":"Zhu","year":"2021","journal-title":"Front Oncol"},{"issue":"11","key":"10.1016\/j.det.2025.03.012_bib27","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1038\/s41379-022-01101-y","article-title":"Breslow thickness 2.0: why gene expression profiling is a step toward better patient selection for sentinel lymph node biopsies","volume":"35","author":"Sadurn\u00ed","year":"2022","journal-title":"Mod Pathol"},{"issue":"15","key":"10.1016\/j.det.2025.03.012_bib28","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.3390\/cancers16152690","article-title":"Adjuvant therapy for high-risk stage II melanoma: current paradigms in management and future directions","volume":"16","author":"Vargas","year":"2024","journal-title":"Cancers (Basel)"},{"issue":"3","key":"10.1016\/j.det.2025.03.012_bib29","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.jaad.2020.03.053","article-title":"Molecular risk prediction in cutaneous melanoma: a meta-analysis of the 31-gene expression profile prognostic test in 1,479 patients","volume":"83","author":"Greenhaw","year":"2020","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.det.2025.03.012_bib30","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1111\/bjd.19499","article-title":"Validation of a clinicopathological and gene expression profile model for sentinel lymph node metastasis in primary cutaneous melanoma","volume":"184","author":"Mulder","year":"2021","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.det.2025.03.012_bib31","article-title":"31-Gene expression profile testing in cutaneous melanoma and survival outcomes in a population-based analysis: a SEER collaboration","volume":"7","author":"Bailey","year":"2023","journal-title":"JCO Precis Oncol"},{"issue":"PO.20","key":"10.1016\/j.det.2025.03.012_bib32","article-title":"Long-term outcomes in a multicenter, prospective cohort evaluating the prognostic 31-Gene expression profile for cutaneous melanoma","volume":"5","author":"Hsueh","year":"2021","journal-title":"JCO Precis Oncol"},{"key":"10.1016\/j.det.2025.03.012_bib33","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/cup.12475","article-title":"Clinical validation of a gene expression signature that differentiates benign nevi from malignant melanoma","volume":"42","author":"Clarke","year":"2015","journal-title":"J Cutan Pathol"},{"issue":"9","key":"10.1016\/j.det.2025.03.012_bib34","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1001\/jamadermatol.2020.1731","article-title":"Performance of gene expression profile tests for prognosis in patients with localized cutaneous melanoma: a systematic review and meta-analysis","volume":"156","author":"Marchetti","year":"2020","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.det.2025.03.012_bib35","unstructured":"National Comprehensive Cancer Network, NCCN clinical practice guidelines in oncology: Cutaneous melanoma. Version [latest version], Available at: https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/cutaneous_melanoma.pdf (Accessed 24 February 2025)."},{"key":"10.1016\/j.det.2025.03.012_bib36","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1056\/NEJMoa1310460","article-title":"Final trial report of sentinel-node biopsy versus nodal observation in melanoma","volume":"370","author":"Morton","year":"2014","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.det.2025.03.012_bib37","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.25251\/skin.7.6.8","article-title":"2023. Response to a letter to the editor regarding \u201cThe Integrated 31-Gene Expression Profile (i31-GEP) Test for Cutaneous Melanoma Outperforms a Clinicopathologic-Only Nomogram at Identifying Patients who can Forego Sentinel Lymph Node Biopsy\u201d","volume":"7","author":"Zakria","year":"2023","journal-title":"SKIN The Journal of Cutaneous Medicine"},{"issue":"1","key":"10.1016\/j.det.2025.03.012_bib38","doi-asserted-by":"crossref","first-page":"556","DOI":"10.25251\/skin.7.1.1","article-title":"2023. Incorporating prognostic gene expression profile assays into the management of cutaneous melanoma: an expert consensus panel report","volume":"7","author":"Zakria","year":"2023","journal-title":"SKIN The Journal of Cutaneous Medicine"},{"key":"10.1016\/j.det.2025.03.012_bib39","doi-asserted-by":"crossref","unstructured":"Glazer A, Tassavor M, Portela D, et al, The integrated 31-Gene expression profile test (i31-GEP) for cutaneous melanoma outperforms the CP-GEP at identifying patients who can forego sentinel lymph node biopsy when applying NCCN guidelines, SKIN: J Cutan Med, 6 (6), 2022, 474\u2013481, Available at: https:\/\/skin.dermsquared.com\/skin\/article\/view\/1796 (Accessed 24 February 2025).","DOI":"10.25251\/skin.6.6.4"},{"issue":"1","key":"10.1016\/j.det.2025.03.012_bib40","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jaad.2018.07.028","article-title":"Identification of patients at risk of metastasis using a prognostic 31-gene expression profile in subpopulations of melanoma patients with favorable outcomes by standard criteria","volume":"80","author":"Gastman","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.det.2025.03.012_bib41","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1001\/jamadermatol.2023.0127","article-title":"Early detection and prognostic assessment of cutaneous melanoma: consensus on optimal practice and the role of gene expression profile testing","volume":"159","author":"Kashani-Sabet","year":"2023","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.det.2025.03.012_bib42","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1001\/jamadermatol.2022.0970","article-title":"Utility of a model for predicting the risk of sentinel lymph node metastasis in patients with cutaneous melanoma","volume":"158","author":"Marchetti","year":"2022","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.det.2025.03.012_bib43","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1186\/s12957-024-03512-4","article-title":"Integrating the melanoma 31-Gene expression profile test with clinical and pathologic features can provide personalized precision estimates for sentinel lymph node positivity: an independent performance cohort","volume":"22","author":"Kriza","year":"2024","journal-title":"World J Surg Oncol"}],"container-title":["Dermatologic Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733863525000269?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733863525000269?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T21:44:45Z","timestamp":1750974285000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0733863525000269"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":43,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S0733863525000269"],"URL":"https:\/\/doi.org\/10.1016\/j.det.2025.03.012","relation":{},"ISSN":["0733-8635"],"issn-type":[{"value":"0733-8635","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genomics in Assessing Melanoma Prognosis","name":"articletitle","label":"Article Title"},{"value":"Dermatologic Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.det.2025.03.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}